Vaccines are important for public health, but they are less profitable than most biologics, causing only a few manufacturers to produce them. If adverse events following immunization happen and vaccines are regarded as defectively designed or manufactured, then the producer is liable and has to pay massive damages to victims. Vaccine lawsuit threats the manufacturer’s reputation, and is a considerable financial risk. To ensure stable supply, government may need to provide incentives for the production of vaccines. The government can also provide special compensation program to settle vaccine disputes. Although vaccines have indispensable public health value, they have somehow unavoidable risks. To encourage manufacturers’ willingness to produce and people’s willingness to be vaccinated, government needs to design a coherent legal mechanism. The content and subject in the first year: liability’s influences on the production and use of vaccines 1. Will vaccine liability discourage the production of vaccines? 2. Will liability protection for manufacturers encourage the production of vaccines? 3. Will liability protection for healthcare providers who administer vaccines increase immunization rates? The content and subject in the second year: Vaccine injury compensation program’s influences on immunization rates. 1. Can vaccine injury compensation program increase immunization rates? 2. Would vaccine injury compensation program influence vaccine safety perceptions?
|Effective start/end date||1/1/14 → 7/31/15|
- Vaccine liability
- vaccine liability protection
- vaccine injury compensation program
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.